Pan Y, Jia Z, Yu X, Lv H, Zhang Y, Wu Y
PeerJ. 2025; 13:e19021.
PMID: 39995984
PMC: 11849502.
DOI: 10.7717/peerj.19021.
Yang X, Zhang J, Chen S, Liu Z, Poland G, Olatosi B
J Acquir Immune Defic Syndr. 2024; 97(2):107-116.
PMID: 39250644
PMC: 11386905.
DOI: 10.1097/QAI.0000000000003475.
Li J, Xu J, Liu Y, Chen L, Yu L, Xiao X
Hum Vaccin Immunother. 2024; 20(1):2389602.
PMID: 39171541
PMC: 11346555.
DOI: 10.1080/21645515.2024.2389602.
Benhamouda N, Besbes A, Bauer R, Mabrouk N, Gadouas G, Desaint C
iScience. 2024; 27(8):110441.
PMID: 39104410
PMC: 11298648.
DOI: 10.1016/j.isci.2024.110441.
Al-Mhanna S, Batrakoulis A, Sheikh A, Aldayel A, Sabo A, Mohamed M
AIMS Public Health. 2024; 11(2):459-476.
PMID: 39027387
PMC: 11252570.
DOI: 10.3934/publichealth.2024023.
Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina.
Garza-Silva A, Rivera-Salinas D, Rivera-Cavazos A, Fernandez-Chau I, Cepeda-Medina A, Morales-Rodriguez D
Front Immunol. 2024; 15:1403784.
PMID: 38807602
PMC: 11130401.
DOI: 10.3389/fimmu.2024.1403784.
[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases].
Villar-Alvarez F, Martinez-Garcia M, Jimenez D, Farinas-Guerrero F, Ortiz de Lejarazu-Leonardo R, Lopez-Campos J
Open Respir Arch. 2024; 3(2):100097.
PMID: 38620748
PMC: 7983358.
DOI: 10.1016/j.opresp.2021.100097.
Effect of vaccine dose on (SARS-CoV-2) antibody levels in a vaccinated community in Gowa Regency, Indonesia.
Hamsi A, Amiruddin R, Arsin A, Abdullah A, Amqam H, Riskiyani S
J Educ Health Promot. 2024; 13:54.
PMID: 38549660
PMC: 10977628.
DOI: 10.4103/jehp.jehp_886_23.
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study.
Ciccimarra F, Luxi N, Bellitto C, LAbbate L, Raethke M, van Hunsel F
Vaccines (Basel). 2024; 12(3).
PMID: 38543875
PMC: 10974422.
DOI: 10.3390/vaccines12030241.
Effectiveness of mRNA Booster Vaccine Against Coronavirus Disease 2019 Infection and Severe Outcomes Among Persons With and Without Immune Dysfunction: A Retrospective Cohort Study of National Electronic Medical Record Data in the United States.
Sun J, Zheng Q, Anzalone A, Abraham A, Olex A, Zhang Y
Open Forum Infect Dis. 2024; 11(2):ofae019.
PMID: 38379569
PMC: 10878052.
DOI: 10.1093/ofid/ofae019.
B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patients.
Bathish Y, Tuvia N, Eshel E, Tal Lange T, Sigrid Eberhardt C, Edelstein M
Hum Vaccin Immunother. 2024; 20(1):2292376.
PMID: 38191151
PMC: 10793709.
DOI: 10.1080/21645515.2023.2292376.
Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020-2022): A retrospective longitudinal SARS-CoV-2 serological surveillance.
De Pace V, Bruzzone B, Ricucci V, Calcavecchia N, Guarona G, Giberti I
Hum Vaccin Immunother. 2023; 19(2):2258632.
PMID: 37724517
PMC: 10512804.
DOI: 10.1080/21645515.2023.2258632.
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review.
Roslan M, Mohd Nisfu F, Arzmi M, Abdul Wahab R, Zainuddin N
Malays J Med Sci. 2023; 30(4):8-24.
PMID: 37655145
PMC: 10467589.
DOI: 10.21315/mjms2023.30.4.2.
Comparative analysis of the effectiveness difference of SARS-COV-2 mRNA vaccine in different populations in the real world: A review.
Cai S, Chang C, Zhang X, Qiao W
Medicine (Baltimore). 2023; 102(34):e34805.
PMID: 37653835
PMC: 10470718.
DOI: 10.1097/MD.0000000000034805.
Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership.
Berry A, Tjaden A, Renteria J, Friedman-Klabanoff D, Hinkelman A, Gibbs M
Vaccine X. 2023; 15:100371.
PMID: 37649617
PMC: 10462856.
DOI: 10.1016/j.jvacx.2023.100371.
Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study.
Joseph G, Cohen C, Rubin C, Murad H, Indenbaum V, Asraf K
Microorganisms. 2023; 11(7).
PMID: 37512801
PMC: 10384358.
DOI: 10.3390/microorganisms11071628.
Drug Cocktail Formulation via Circuit Design.
Beahm D, Deng Y, DeAngelo T, Sarpeshkar R
IEEE Trans Mol Biol Multiscale Commun. 2023; 9(1):28-48.
PMID: 37397625
PMC: 10312325.
DOI: 10.1109/tmbmc.2023.3246928.
Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups.
Das D, Raha F, Adnan K, Siraj M, Shapla M, Shumy F
Heliyon. 2023; 9(5):e16349.
PMID: 37251854
PMC: 10199753.
DOI: 10.1016/j.heliyon.2023.e16349.
Real-World Effectiveness of Four Types of COVID-19 Vaccines.
H Abdel-Qader D, Abdel-Qader H, Silverthorne J, Kongkaew C, Al Meslamani A, Hayajneh W
Vaccines (Basel). 2023; 11(5).
PMID: 37243089
PMC: 10224211.
DOI: 10.3390/vaccines11050985.
Long COVID and Hybrid Immunity among Children and Adolescents Post-Delta Variant Infection in Thailand.
Jarupan M, Jantarabenjakul W, Jaruampornpan P, Subchartanan J, Phasomsap C, Sritammasiri T
Vaccines (Basel). 2023; 11(5).
PMID: 37242988
PMC: 10223729.
DOI: 10.3390/vaccines11050884.
